Look for:

Our offer for

KONINKLIJKE PHILIPS NV


ISIN:
NL0000009538
WKN:
0953

2024/03/28 17:35:12
Price
18.606 EUR
Difference -0.95% (-0.18)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,838 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.55 EUR (12)
Ask (Ask size)18.81 EUR (208)
Open18.756 EUR
High18.858 EUR
Low18.546 EUR
Close (prev. day)18.784 EUR
VWAP18.630032 EUR
Volume (pcs)2,077,535
Trading volume38,704,542.00
Number of trades4,129
Last size268

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 17:35:12
Price
18.606 EUR
Difference -0.95% (-0.18)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,838 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.55 EUR (12)
Ask (Ask size)18.81 EUR (208)
Open18.756 EUR
High18.858 EUR
Low18.546 EUR
Close (prev. day)18.784 EUR
VWAP18.630032 EUR
Volume (pcs)2,077,535
Trading volume38,704,542.00
Number of trades4,129
Last size268

Performance and Risk

6m1Y3Y
Perf (%)-1.36%+29.25%-59.59%
Perf (abs.)-0.26+4.21-27.44
Beta0.600.670.93
Volatility26.1528.6934.75
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)18.594 EUR (1,690,682)
Ø price 30 days | Ø volume 30 days (pcs.)18.888 EUR (1,815,203)
Ø price 100 days | Ø volume 100 days (pcs.)19.668 EUR (2,147,784)
Ø price 250 days | Ø volume 250 days (pcs.)19.155 EUR (2,289,674)
YTD High | date22.175 EUR (2024/01/09)
YTD Low | date18.092 EUR (2024/02/21)
52 Weeks High | date22.175 EUR (2024/01/09)
52 Weeks Low | date14.445 EUR (2023/03/29)

All listings for KONINKLIJKE PHILIPS NV

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BX Swiss2024/03/2718:0018.286 CHF0.002
Berlin2024/03/2821:5218.612 EUR0.0017
Duesseldorf2024/03/2819:3018.542 EUR0.006
Euronext Amsterdam2024/03/2817:3518.606 EUR38.704,129
Euronext Milan MTF Global Equity Market2024/03/2817:4418.602 EUR0.028
Euronext Milan MTF Trading After Hours2024/02/0918:0018.20 EUR0.002
FINRA other OTC Issues2024/03/2816:2720.15 USD0.232
Frankfurt2024/03/2817:1518.60 EUR0.018
Hamburg2024/03/2813:3718.756 EUR0.022
Hanover2024/03/2808:1118.784 EUR0.003
London Stock Exchange European Trade Reporting2024/03/2817:3018.616 EUR0.001
Munich2024/03/2808:0018.834 EUR0.002
SIX Swiss Exchange2022/06/0215:2047.0683 CHF0.001
Stuttgart2024/03/2816:2018.672 EUR0.0112
Tradegate2024/03/2822:2618.604 EUR0.0945
Vienna Stock Exchange2024/03/2809:0518.82 EUR0.003
Xetra2024/03/2817:3518.606 EUR0.2762

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2324&ID_TYPE_IMAGE_LOGO=2

Contact Details

KONINKLIJKE PHILIPS NV
- -
Philips Center, Amstelplein 2 - 1096 BC Amsterdam
Telefon: +31-20-597-77-77
Fax: +
E-mail: -

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Company Profile

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Members of Management Board

Frans von HoutenChairman of Managing Board
Abhijit BhattacharyaMember of Executive Committee
Andy HoMember of Executive Committee
Bert van MeursMember of Executive Committee
Daniela SeabrookMember of Executive Committee
Deeptha KhannaMember of Executive Committee
Edwin PaalvastMember of Executive Committee
Kees WesdorpMember of Executive Committee
Marnix van GinnekenMember of Executive Committee
Roy JakobsMember of Executive Committee
Shez PartoviMember of Executive Committee
Sophie BechuMember of Executive Committee
Vitor RochaMember of Executive Committee

Board of directors

Feike SijbesmaChairman of Supervisory Board
A. HarrisonMember of Supervisory Board
Paulus StoffelsMember of Supervisory Board
David PyottMember of Supervisory Board
Hendrica VerhagenMember of Supervisory Board
Indra Krishnamurthy NooyiMember of Supervisory Board
Mary DohertyMember of Supervisory Board
Peter D. LöscherMember of Supervisory Board
Sanjay PoonenMember of Supervisory Board
Sock Koong ChuaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer